Assessing Force Feedback With the SoftHand Pro (CUFF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03412656|
Recruitment Status : Recruiting
First Posted : January 26, 2018
Last Update Posted : March 22, 2018
|Condition or disease||Intervention/treatment||Phase|
|Amputation, Traumatic Limb Defect||Device: SHPro with CUFF||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Device Feasibility|
|Official Title:||Assessing the Effectiveness of Upper-limb Force Feedback With the SoftHand Pro Myoelectric Prosthesis in Persons With Transradial Limb Loss|
|Actual Study Start Date :||October 17, 2017|
|Estimated Primary Completion Date :||December 31, 2018|
|Estimated Study Completion Date :||December 31, 2019|
Device: SHPro with CUFF
Participants will complete various movement and activity of daily living (ADL) assessments to test the effectiveness of the CUFF device in combination with the Soft Hand Pro (SHP) in conveying haptic force feedback to patients with transradial limb loss, and to assess the extent to which the grip force feedback improves the embodiment of the prosthetic device.
- Conveyance of force feedback [ Time Frame: 1 year ]Assessments will measure the extent to which the CUFF device conveys haptic force feedback, when used in combination with the Soft Hand Pro.
- Improvement to device embodiment through addition of grip force feedback [ Time Frame: 1 year ]Assessments will determine any improvement of device embodiment from the addition of grip force feedback to the Soft Hand Pro.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03412656
|Contact: Tyson L. Scrabeck||(507)email@example.com|
|United States, Minnesota|
|Mayo Clinic in Rochester||Recruiting|
|Rochester, Minnesota, United States, 55905|
|Contact: Tyson L. Scrabeck 507-538-1016 firstname.lastname@example.org|
|Principal Investigator:||Kristin D. Zhao, Ph.D.||Mayo Clinic|
|Principal Investigator:||Karen L. Andrews, M.D.||Mayo Clinic|